Indigent Patient Program

Ucyclyd Pharma has established a patient assistance program to make BuphenylŪ, (sodium phenylbutyrate) tablets and powder, available to patients in need of financial assistance. The National Organization of Rare Diseases (NORD) administers the program for Ucyclyd Pharma. Determination of eligibility is based on need and not on financial income.

Criteria for Participation Include:

Once your application is approved medication will be shipped directly to your home. You will be billed for shipping charges.

Further information on the National Organization of Rare Diseases patient assistant programs is available at www.rarediseases.org/programs/medication. Scroll to the bottom of the page to find Ucyclyd Pharma, Inc.